- Home
- TRIB vs EDSA Comparison
TRIB vs EDSA Comparison
Compare TRIB & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- EDSA
- Stock Information
- Founded
- TRIB 1992
- EDSA 2015
- Country
- TRIB Ireland
- EDSA Canada
- Employees
- TRIB N/A
- EDSA N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- EDSA Health Care
- Exchange
- TRIB Nasdaq
- EDSA Nasdaq
- Market Cap
- TRIB 15.9M
- EDSA 13.5M
- IPO Year
- TRIB N/A
- EDSA N/A
- Fundamental
- Price
- TRIB $1.55
- EDSA $3.76
- Analyst Decision
- TRIB
- EDSA Strong Buy
- Analyst Count
- TRIB 0
- EDSA 1
- Target Price
- TRIB N/A
- EDSA $21.00
- AVG Volume (30 Days)
- TRIB 158.6K
- EDSA 14.8K
- Earning Date
- TRIB 08-14-2024
- EDSA 12-13-2024
- Dividend Yield
- TRIB N/A
- EDSA N/A
- EPS Growth
- TRIB N/A
- EDSA N/A
- EPS
- TRIB N/A
- EDSA N/A
- Revenue
- TRIB $58,652,000.00
- EDSA N/A
- Revenue This Year
- TRIB $17.64
- EDSA N/A
- Revenue Next Year
- TRIB $9.84
- EDSA N/A
- P/E Ratio
- TRIB N/A
- EDSA N/A
- Revenue Growth
- TRIB 8.60
- EDSA N/A
- 52 Week Low
- TRIB $1.05
- EDSA $2.50
- 52 Week High
- TRIB $3.55
- EDSA $6.46
- Technical
- Relative Strength Index (RSI)
- TRIB 48.81
- EDSA 33.53
- Support Level
- TRIB $1.52
- EDSA $4.01
- Resistance Level
- TRIB $1.83
- EDSA $4.36
- Average True Range (ATR)
- TRIB 0.16
- EDSA 0.24
- MACD
- TRIB 0.04
- EDSA -0.04
- Stochastic Oscillator
- TRIB 50.00
- EDSA 8.24
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.